Article Details
Retrieved on: 2021-06-30 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Meissa Vaccines (“Meissa”), a biotechnology company developing ... using the company's proprietary AttenuBlock TM synthetic biology platform with ...
Article found on: www.galvnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here